Annual Current Liabilities
$30.95 M
+$9.01 M+41.09%
December 31, 2023
Summary
- As of February 28, 2025, ACRS annual total current liabilities is $30.95 million, with the most recent change of +$9.01 million (+41.09%) on December 31, 2023.
- During the last 3 years, ACRS annual current liabilities has risen by +$16.08 million (+108.09%).
- ACRS annual current liabilities is now at all-time high.
Performance
ACRS Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Liabilities
$18.82 M
+$3.13 M+19.98%
September 30, 2024
Summary
- As of February 28, 2025, ACRS quarterly total current liabilities is $18.82 million, with the most recent change of +$3.13 million (+19.98%) on September 30, 2024.
- Over the past year, ACRS quarterly current liabilities has dropped by -$8.50 million (-31.13%).
- ACRS quarterly current liabilities is now -55.98% below its all-time high of $42.75 million, reached on June 30, 2019.
Performance
ACRS Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
ACRS Current Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +41.1% | -31.1% |
| 3 y3 years | +108.1% | +5.5% |
| 5 y5 years | +13.2% | -51.7% |
ACRS Current Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +41.1% | -39.2% | +20.0% |
| 5 y | 5-year | at high | +108.1% | -39.2% | +47.1% |
| alltime | all time | at high | +8333.8% | -56.0% | +1221.3% |
Aclaris Therapeutics Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $18.82 M(+20.0%) |
| Jun 2024 | - | $15.68 M(-21.9%) |
| Mar 2024 | - | $20.08 M(-35.1%) |
| Dec 2023 | $30.95 M(+41.1%) | $30.95 M(+13.3%) |
| Sep 2023 | - | $27.32 M(+19.7%) |
| Jun 2023 | - | $22.83 M(+25.0%) |
| Mar 2023 | - | $18.26 M(-16.8%) |
| Dec 2022 | $21.94 M(-4.3%) | $21.94 M(+10.9%) |
| Sep 2022 | - | $19.79 M(+22.0%) |
| Jun 2022 | - | $16.22 M(-3.0%) |
| Mar 2022 | - | $16.73 M(-27.1%) |
| Dec 2021 | $22.93 M(+54.2%) | $22.93 M(+28.5%) |
| Sep 2021 | - | $17.84 M(+19.6%) |
| Jun 2021 | - | $14.92 M(+2.8%) |
| Mar 2021 | - | $14.51 M(-2.5%) |
| Dec 2020 | $14.87 M(-33.7%) | $14.87 M(+16.3%) |
| Sep 2020 | - | $12.79 M(-27.9%) |
| Jun 2020 | - | $17.75 M(-13.9%) |
| Mar 2020 | - | $20.60 M(-8.2%) |
| Dec 2019 | $22.43 M | $22.43 M(-42.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2019 | - | $38.99 M(-8.8%) |
| Jun 2019 | - | $42.75 M(+18.0%) |
| Mar 2019 | - | $36.23 M(+32.5%) |
| Dec 2018 | $27.34 M(+114.2%) | $27.34 M(+22.7%) |
| Sep 2018 | - | $22.28 M(+11.0%) |
| Jun 2018 | - | $20.07 M(+45.2%) |
| Mar 2018 | - | $13.82 M(+8.3%) |
| Dec 2017 | $12.76 M(+105.1%) | $12.76 M(+27.7%) |
| Sep 2017 | - | $9.99 M(+19.4%) |
| Jun 2017 | - | $8.37 M(+48.5%) |
| Mar 2017 | - | $5.64 M(-9.4%) |
| Dec 2016 | $6.22 M(+300.2%) | $6.22 M(+35.5%) |
| Sep 2016 | - | $4.59 M(-16.6%) |
| Jun 2016 | - | $5.51 M(+47.7%) |
| Mar 2016 | - | $3.73 M(+139.8%) |
| Dec 2015 | $1.55 M(+7.2%) | $1.55 M(-18.0%) |
| Sep 2015 | - | $1.90 M(+33.2%) |
| Jun 2015 | - | $1.42 M(-1.9%) |
| Dec 2014 | $1.45 M(+295.4%) | $1.45 M |
| Dec 2013 | $367.00 K | - |
FAQ
- What is Aclaris Therapeutics annual total current liabilities?
- What is the all time high annual current liabilities for Aclaris Therapeutics?
- What is Aclaris Therapeutics annual current liabilities year-on-year change?
- What is Aclaris Therapeutics quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Aclaris Therapeutics?
- What is Aclaris Therapeutics quarterly current liabilities year-on-year change?
What is Aclaris Therapeutics annual total current liabilities?
The current annual current liabilities of ACRS is $30.95 M
What is the all time high annual current liabilities for Aclaris Therapeutics?
Aclaris Therapeutics all-time high annual total current liabilities is $30.95 M
What is Aclaris Therapeutics annual current liabilities year-on-year change?
Over the past year, ACRS annual total current liabilities has changed by +$9.01 M (+41.09%)
What is Aclaris Therapeutics quarterly total current liabilities?
The current quarterly current liabilities of ACRS is $18.82 M
What is the all time high quarterly current liabilities for Aclaris Therapeutics?
Aclaris Therapeutics all-time high quarterly total current liabilities is $42.75 M
What is Aclaris Therapeutics quarterly current liabilities year-on-year change?
Over the past year, ACRS quarterly total current liabilities has changed by -$8.50 M (-31.13%)